NASDAQ:BIB ProShares Ultra Nasdaq Biotechnology - BIB Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. $59.00 -1.21 (-2.01%) (As of 02/7/2023 12:40 PM ET) Add Share Share Today's Range$58.85▼$60.2950-Day Range$55.27▼$64.0552-Week Range$38.42▼$67.31Volume12,863 shsAverage Volume33,283 shsMarket Capitalization$112.10 millionP/E RatioN/ADividend Yield0.03%Price TargetN/A ProfileChartDividendInstitutional OwnershipHeadlinesOptions ChainSocial Media Receive BIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive BIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Basic Details Issuer ProShares Fund NameProShares Ultra Nasdaq Biotechnology Tax ClassificationRegulated Investment Company SymbolNASDAQ:BIB Inception Date4/6/2010 Fund ManagerMichael Neches, Tarak Dave Webwww.proshares.com Phone+1-240-4976400Fund Focus Asset ClassEquity BenchmarkNasdaq Biotech Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$193.76 million Average Daily Volume$162,193.00 Discount/Premium-0.09% ETF Expenses Management Fee0.75% Other Expenses0.29% Total Expenses1.04% Fee Waiver-0.09% Net Expenses0.95%Administrator, Advisor and Custodian AdministratorJ.P. Morgan Investor Services Co. AdvisorProShare Advisors LLC CustodianJPMorgan Chase Bank, N.A. DistributorSEI Investments Distribution Co. Transfer AgentJPMorgan Chase Bank, N.A. Trustee Lead Market MakerVirtu Financial Geographic Exposure of BIBCurrency Exposure of BIBSector Exposure of BIBIndustry Exposure of BIB Insiders & InstitutionsToth Financial Advisory CorpBought 9,440 shares on 1/24/2023Ownership: 0.970%Private Advisor Group LLCBought 4,000 shares on 1/18/2023Ownership: 0.229%Citadel Advisors LLCSold 2,300 shares on 11/15/2022Ownership: 0.000%Wolverine Trading LLCSold 4,000 shares on 11/14/2022Ownership: 0.000%UBS Group AGBought 784 shares on 11/10/2022Ownership: 0.062%View All Institutional Transactions BIB Stock - Frequently Asked Questions How have BIB shares performed in 2023? ProShares Ultra Nasdaq Biotechnology's stock was trading at $57.70 on January 1st, 2023. Since then, BIB shares have increased by 4.4% and is now trading at $60.21. View the best growth stocks for 2023 here. How often does ProShares Ultra Nasdaq Biotechnology pay dividends? What is the dividend yield for ProShares Ultra Nasdaq Biotechnology? ProShares Ultra Nasdaq Biotechnology announced a quarterly dividend on Wednesday, December 21st. Stockholders of record on Friday, December 23rd will be paid a dividend of $0.02 per share on Friday, December 30th. This represents a $0.08 dividend on an annualized basis and a yield of 0.13%. The ex-dividend date of this dividend is Thursday, December 22nd. Read our dividend analysis for BIB. Is ProShares Ultra Nasdaq Biotechnology a good dividend stock? ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) pays an annual dividend of $0.02 per share and currently has a dividend yield of 0.03%. Read our dividend analysis for BIB. What other stocks do shareholders of ProShares Ultra Nasdaq Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares Ultra Nasdaq Biotechnology investors own include Walt Disney (DIS), Gilead Sciences (GILD), Micron Technology (MU), NVIDIA (NVDA), Starbucks (SBUX), Advanced Micro Devices (amd), Alibaba Group (BABA), Pfizer (PFE), Intel (INTC) and Visa (V). What is ProShares Ultra Nasdaq Biotechnology's stock symbol? ProShares Ultra Nasdaq Biotechnology trades on the NASDAQ under the ticker symbol "BIB." Who are ProShares Ultra Nasdaq Biotechnology's major shareholders? ProShares Ultra Nasdaq Biotechnology's stock is owned by a variety of retail and institutional investors. Top institutional investors include Toth Financial Advisory Corp (0.97%) and Private Advisor Group LLC (0.23%). How do I buy shares of ProShares Ultra Nasdaq Biotechnology? Shares of BIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is ProShares Ultra Nasdaq Biotechnology's stock price today? One share of BIB stock can currently be purchased for approximately $60.21. How much money does ProShares Ultra Nasdaq Biotechnology make? ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) has a market capitalization of $114.40 million. How can I contact ProShares Ultra Nasdaq Biotechnology? ProShares Ultra Nasdaq Biotechnology's mailing address is SUITE 1000, 7501 WISCONSIN AVENUE, BETHESDA, MD 20814, United States. The official website for the company is www.proshares.com. The exchange traded fund can be reached via phone at +1-240-4976400. This page (NASDAQ:BIB) was last updated on 2/7/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.